Sort   by:  
 Page size 
UnknownAdipose-derived mesenchymal stem cells for the treatment of Amyotrophic Lateral Sclerosis. A phase I/II safety and efficacy clinical trial.
Not available
S-EPMC12540107 | biostudies-literature
UnknownClinical Predictive Model of Multidrug Resistance in Neutropenic Cancer Patients with Bloodstream Infection Due to Pseudomonas aeruginosa.
Not available
S-EPMC7179320 | biostudies-literature
UnknownIdentification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study.
Not available
S-EPMC7906623 | biostudies-literature
UnknownCharacteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain.
Not available
S-EPMC7399713 | biostudies-literature
UnknownDevelopment and validation of a prediction model for 30-day mortality in hospitalised patients with COVID-19: the COVID-19 SEIMC score.
Not available
S-EPMC7908055 | biostudies-literature
UnknownThe evolution of the ventilatory ratio is a prognostic factor in mechanically ventilated COVID-19 ARDS patients.
Not available
S-EPMC8436582 | biostudies-literature
UnknownRemdesivir and survival outcomes in critically ill patients with COVID-19: A multicentre observational cohort study.
Not available
S-EPMC9804970 | biostudies-literature
UnknownClustering COVID-19 ARDS patients through the first days of ICU admission. An analysis of the CIBERESUCICOVID Cohort.
Not available
S-EPMC10958830 | biostudies-literature
UnknownProcalcitonin and C-reactive protein to rule out early bacterial coinfection in COVID-19 critically ill patients.
Not available
S-EPMC10425511 | biostudies-literature
UnknownMajor candidate variables to guide personalised treatment with steroids in critically ill patients with COVID-19: CIBERESUCICOVID study.
Not available
S-EPMC9211796 | biostudies-literature
Sort   by:  
 Page size